Histone deacetylase 6 is a multifunctional lysine deacetylase that is recently emerging as a central facilitator of response to stress and may play an important role in cancer cell proliferation. The histone deacetylase 6-inhibitor tubacin has been shown to slow the growth of metastatic prostate cancer cells and sensitize cancer cells to chemotherapeutic agents. However, the proteins histone deacetylase 6 interacts with, and thus its role in cancer cells, remains poorly characterized. Histone deacetylase 6 deacetylase activity has recently been shown to be required for efficient basal autophagic flux. Autophagy is often dysregulated in cancer cells and may confer stress resistance and allow for cell maintenance and a high proliferation rate. Tubacin may therefore slow cancer cell proliferation by decreasing autophagic flux. We characterized the histone deacetylase 6-interacting proteins in LNCaP metastatic prostate cancer cells and found that histone deacetylase 6 interacts with proteins involved in several cellular processes, including autophagy. Based on our interaction screen, we assessed the impact of the histone deacetylase 6-inhibitor tubacin on autophagic flux in two metastatic prostate cancer cell lines and found that tubacin does not influence autophagic flux. Histone deacetylase 6 therefore influences cell proliferation through an autophagy-independent mechanism.
MatthiasPYoshidaMKhochbinS. HDAC6 a new cellular stress surveillance factor. Cell Cycle2008; 7: 7–10.
2.
KawaguchiYKovacsJJMcLaurinAVanceJMItoAYaoTP. The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress. Cell2003; 115: 727–38.
3.
IwataARileyBEJohnstonJAKopitoRR. HDAC6 and microtubules are required for autophagic degradation of aggregated huntingtin. J Biol Chem2005; 280: 40282–92.
4.
BoyaultCZhangYFritahSCaronCGilquinBKwonSHGarridoCYaoTPVourc'hCMatthiasPKhochbinS. HDAC6 controls major cell response pathways to cytotoxic accumulation of protein aggregates. Genes Dev2007; 21: 2172–81.
KwonSZhangYMatthiasP. The deacetylase HDAC6 is a novel critical component of stress granules involved in the stress response. Genes Dev2007; 21: 3381–94.
7.
ZhangLLiuSLiuNZhangYLiuMLiDSetoEYaoTPShuiWZhouJ. Proteomic identification and functional characterization of MYH9, Hsc70, and DNAJA1 as novel substrates of HDAC6 deacetylase activity. Protein Cell2014; 6: 42–54.
8.
DompierreJPGodinJDCharrinBCCordelieresFPKingSJHumbertSSaudouF. Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington's disease by increasing tubulin acetylation. J Neurosci2007; 27: 3571–83.
9.
FungCLockRGaoSSalasEDebnathJ. Induction of autophagy during extracellular matrix detachment promotes cell survival. Mol Biol Cell2008; 19: 797–806.
10.
KimJKJungYWangJJosephJMishraAHillEEKrebsbachPHPientaKJShiozawaYTaichmanRS. TBK1 regulates prostate cancer dormancy through mTOR inhibition. Neoplasia2013; 15: 1064–74.
11.
KenificCMThorburnADebnathJ. Autophagy and metastasis: another double-edged sword. Curr Opin Cell Biol2009; 22: 241–5.
12.
YangZJCheeCEHuangSSinicropeFA. The role of autophagy in cancer: therapeutic implications. Mol Cancer Ther2011 Sep; 10: 1533–41.
13.
WhiteE. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer2012; 12: 401–10.
14.
NamdarMPerezGNgoLMarksPA. Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents. Proc Natl Acad Sci USA2010; 107: 20003–8.
15.
RaoRFiskusWYangYLeePJoshiRFernandezPMandawatAAtadjaPBradnerJEBhallaK. HDAC6 inhibition enhances 17-AAG–mediated abrogation of hsp90 chaperone function in human leukemia cells. Blood2008; 112: 1886–93.
16.
Aldana-MasangkayGIRodriguez-GonzalezALinTIkedaAKHsiehYTKimYMLomenickBOkemotoKLandawEMWangDMazitschekRBradnerJESakamotoKM. Tubacin suppresses proliferation and induces apoptosis of acute lymphoblastic leukemia cells. Leuk Lymphoma2011; 52: 1544–55.
17.
Aldana-MasangkayGISakamotoKM. The role of HDAC6 in cancer. J Biomed Biotechnol2010; 2011: 875824–875824.
18.
GaoJAksoyBADogrusozUDresdnerGGrossBSumerSOSunYJacobsenASinhaRLarssonECeramiESanderCSchultzN. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signaling2013; 6: l1–l1.
19.
CeramiEGaoJDogrusozUGrossBESumerSOAksoyBAJacobsenAByrneCJHeuerMLLarssonEAntipinYRevaBGoldbergAPSanderCSchultzN. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov2012; 2: 401–4.
KlionskyDJAbeliovichHAgostinisPAgrawalDKAlievGAskewDSBabaMBaehreckeEHBahrBABallabioABamberBABasshamDCBergaminiEBiXBiard-PiechaczykMBlumJSBredesenDEBrodskyJLBrumellJHBrunkUTBurschWCamougrandNCebolleroECecconiFChenYChinLSChoiAChuCTChungJClarkePGClarkRSClarkeSGClaveCClevelandJLCodognoPColomboMICoto-MontesACreggJMCuervoAMDebnathJDemarchiFDennisPBDennisPADereticVDevenishRJDi SanoFDiceJFDifigliaMDinesh-KumarSDistelhorstCWDjavaheri-MergnyMDorseyFCDrogeWDronMDunnWA Jr.DuszenkoMEissaNTElazarZEsclatineAEskelinenELFesusLFinleyKDFuentesJMFueyoJFujisakiKGalliotBGaoFBGewirtzDAGibsonSBGohlaAGoldbergALGonzalezRGonzalez-EstevezCGorskiSGottliebRAHaussingerDHeYWHeidenreichKHillJAHoyer-HansenMHuXHuangWPIwasakiAJaattelaMJacksonWTJiangXJinSJohansenTJungJUKadowakiMKangCKelekarAKesselDHKielJAKimHPKimchiAKinsellaTJKiselyovKKitamotoKKnechtEKomatsuMKominamiEKondoSKovacsALKroemerGKuanCYKumarRKunduMLandryJLaporteMLeWLeiHYLenardoMJLevineBLiebermanALimKLLinFCLiouWLiuLFLopez-BeresteinGLopez-OtinCLuBMacleodKFMalorniWMartinetWMatsuokaKMautnerJMeijerAJMelendezAMichelsPMiottoGMistiaenWPMizushimaNMograbiBMonastyrskaIMooreMNMoreiraPIMoriyasuYMotylTMunzCMurphyLONaqviNINeufeldTPNishinoINixonRANodaTNurnbergBOgawaMOleinickNLOlsenLJOzpolatBPaglinSPalmerGEPapassideriIParkesMPerlmutterDHPerryGPiacentiniMPinkas-KramarskiRPrescottMProikas-CezanneTRabenNRamiAReggioriFRohrerBRubinszteinDCRyanKMSadoshimaJSakagamiHSakaiYSandriMSasakawaCSassMSchneiderCSeglenPOSeleverstovOSettlemanJShackaJJShapiroIMSibirnyASilva-ZacarinECSimonHUSimoneCSimonsenASmithMASpanel-BorowskiKSrinivasVSteevesMStenmarkHStromhaugPESubausteCSSugimotoSSulzerDSuzukiTSwansonMSTabasITakeshitaFTalbotNJTalloczyZTanakaKTanakaKTanidaITaylorGSTaylorJPTermanATettamantiGThompsonCBThummMTolkovskyAMToozeSATruantRTumanovskaLVUchiyamaYUenoTUzcateguiNLvan der KleiIVaqueroECVellaiTVogelMWWangHGWebsterPWileyJWXiZXiaoGYahalomJYangJMYapGYinXMYoshimoriTYuLYueZYuzakiMZabirnykOZhengXZhuXDeterRL. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy2008; 4: 151–75.
22.
SchindelinJArganda-CarrerasIFriseEKaynigVLongairMPietzschTPreibischSRuedenCSaalfeldSSchmidBTinevezJYWhiteDJHartensteinVEliceiriKTomancakPCardonaA. Fiji: an open-source platform for biological-image analysis. Nature Methods2012; 9: 676–82.
23.
WatsonGWWickramasekaraSPalomera-SanchezZBlackCMaierCSWilliamsDEDashwoodRHHoE. SUV39H1/H3K9me3 attenuates sulforaphane-induced apoptotic signaling in PC3 prostate cancer cells. Oncogenesis2014; 3: e131–e131.
24.
BoyaultCSadoulKPabionMKhochbinS. HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination. Oncogene2007; 26: 5468–76.
25.
Valenzuela-FernandezACabreroJRSerradorJMSanchez-MadridF. HDAC6: a key regulator of cytoskeleton, cell migration and cell-cell interactions. Trends Cell Biol2008; 18: 291–7.
26.
HubbertCGuardiolaAShaoRKawaguchiYItoANixonAYoshidaMWangXFYaoTP. HDAC6 is a microtubule-associated deacetylase. Nature2002; 417: 455–8.
27.
ZhangXYuanZZhangYYongSSalas-BurgosAKoomenJOlashawNParsonsJTYangXJDentSRYaoTPLaneWSSetoE. HDAC6 modulates cell motility by altering the acetylation level of cortactin. Mol Cell2007; 27: 197–213.
28.
KovacsJJMurphyPJGaillardSZhaoXWuJTNicchittaCVYoshidaMToftDOPrattWBYaoTP. HDAC6 regulates Hsp90 acetylation and chaperone-dependent activation of glucocorticoid receptor. Molecular Cell2005; 18: 601–7.
29.
RandowFYouleRJ. Self and nonself: how autophagy targets mitochondria and bacteria. Cell Host Microbe2014; 15: 403–11.
30.
LeeJYNaganoYTaylorJPLimKLYaoTP. Disease-causing mutations in Parkin impair mitochondrial ubiquitination, aggregation, and HDAC6-dependent mitophagy. J Cell Biol2010; 189: 671–9.
31.
KunduMLindstenTYangCYWuJZhaoFZhangJSelakMANeyPAThompsonCB. Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood2008; 112: 1493–502.
32.
PagliariniDJCalvoSEChangBShethSAVafaiSBOngSEWalfordGASugianaCBonehAChenWKHillDEVidalMEvansJGThorburnDRCarrSAMoothaVK. A mitochondrial protein compendium elucidates complex I disease biology. Cell2008; 134: 112–23.
33.
CuervoAMWongE. Chaperone-mediated autophagy: roles in disease and aging. Cell Res2013; 24: 92–104.
34.
LvLLiDZhaoDLinRChuYZhangHZhaZLiuYLiZXuYWangGHuangYXiongYGuanKLLeiQY. Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth. Mol Cell2011; 42: 719–30.
35.
SchneiderJLSuhYCuervoAM. Deficient chaperone-mediated autophagy in liver leads to metabolic dysregulation. Cell Metab2014; 20: 417–32.
36.
MizushimaNYoshimoriTLevineB. Methods in mammalian autophagy research. Cell2010; 140: 313–26.
37.
YanJSeibenhenerMLCalderilla-BarbosaLDiaz-MecoMTMoscatJJiangJ. SQSTM1/p62 interacts with HDAC6 and regulates deacetylase activity. PloS One2013; 8: e76016–e76016.
38.
ZhangYKwonSYamaguchiTCubizollesFRousseauxSKneisselMCaoCLiNChengHLChuaKLombardDMizerackiAMatthiasGAltFWKhochbinSMatthiasP. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Molecular Cell Biol2008; 28: 1688–701.
39.
HanahanDWeinbergRA. Hallmarks of cancer: the next generation. Cell2011; 144: 646–74.
40.
AltomareDATestaJR. Perturbations of the AKT signaling pathway in human cancer. Oncogene2005; 24: 7455–64.
41.
MajumderPKSellersWR. Akt-regulated pathways in prostate cancer. Oncogene2005; 24: 7465–74.
42.
JungCHRoSHCaoJOttoNMKimDH. mTOR regulation of autophagy. FEBS Lett2010; 584: 1287–95.
43.
VlietstraRJvan AlewijkDCHermansKGvan SteenbruggeGJTrapmanJ. Frequent inactivation of PTEN in prostate cancer cell lines and xenografts. Cancer Res1998; 58: 2720–3.
44.
WuXSenechalKNeshatMSWhangYESawyersCL. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA1998; 95: 15587–91.
45.
DuranAAmanchyRLinaresJFJoshiJAbu-BakerSPorolloAHansenMMoscatJDiaz-MecoMT. p62 is a key regulator of nutrient sensing in the mTORC1 pathway. Mol Cell2011; 44: 134–46.
46.
MoscatJDiaz-MecoMT. p62 at the crossroads of autophagy, apoptosis, and cancer. Cell2009; 137: 1001–4.
47.
MoscatJDiaz-MecoMT. p62: a versatile multitasker takes on cancer. Trends Biochem Sci2012; 37: 230–6.
48.
KirkinVLamarkTSouYSBjorkoyGNunnJLBruunJAShvetsEMcEwanDGClausenTHWildPBilusicITheurillatJPOvervatnAIshiiTElazarZKomatsuMDikicIJohansenT. A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. Mol Cell2009; 33: 505–16.
49.
WongYCHolzbaurEL. Optineurin is an autophagy receptor for damaged mitochondria in Parkin-mediated mitophagy that is disrupted by an ALS-linked mutation. Proc Natl Acad Sci USA2014; 111: E4439–48.
HaoRNanduriPRaoYPanichelliRSItoAYoshidaMYaoTP. Proteasomes activate aggresome disassembly and clearance by producing unanchored ubiquitin chains. Mol Cell2013; 51: 819–28.
54.
WatanabeYTanakaM. p62/SQSTM1 in autophagic clearance of a non-ubiquitylated substrate. J Cell Sci2011; 124(Pt 16): 2692–701.
55.
KroemerGMarinoGLevineB. Autophagy and the integrated stress response. Mol Cell2010; 40: 280–93.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
